Sign in
CompletedNo phase

Hypothalamic-pituitary Dysfunction in Diabetes

Key facts

Who runs it
Istituto Auxologico Italiano
Where
Italy2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
200 people enrolled
Started
25 May 2018
Ended
14 Mar 2024
Type of study
Observational
Treatments tested
  • Diagnostic testing
Record updated
15 March 2024

Who can take part

Age
18 years to 80 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • age between 18 and 80 years old
  • males
  • proved diagnosis of T2DM

Who cannot take part

  • patients affected with known hypothalamic-pituitary diseases at the enrollment
  • patients affected with known primary diseases of the testes at the enrollment
  • patients affected with severe systemic diseases, fever, chronic inflammatory disorders with PCR > 10 mg/dL
  • malnutrition with BMI <17 Kg/m2
  • use of glucocorticoids at the enrollment
  • poor understanding of spoken and written Italian

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Type 2 Diabetes mellitus (T2DM) is a chronic disease with a high prevalence and several comorbidities impacting on public health and society. Among the complications of T2DM it has been showed a high prevalence of hypogonadotropic hypogonadism. Even if hypogonadism is associated to a worse metabolic profile and cardiovascular risk, it is discussed whether and when to treat this potentially reversible form associated to diabetes. In fact, the pathogenic mechanism of this condition in diabetic patients is not fully understood, and its clinical correlates, including the prevalence of other possible associated hypothalamic-pituitary axes dysfunctioning, questioned. The aim of the present study is to assess with an observational, cross sectional study on a large series of type 2 diabetic patients, enrolled consecutively: all the suspected etiologies of this complication in one single evaluation (both acquired and genetic congenital predisposition), its clinical correlates and the real prevalence of the disease using the lastly validated criteria for late onset hypogonadotropic hypogonadism.

The group in the trial

  • Enrolled patients with DM

    Treatment: Diagnostic testing

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Study of the Hypothalamic-pituitary Dysfuntion in Patients With Diabetes Mellitus
Record updated
15 March 2024